Abstract
With the aim of developing a model mimicking the relapse of patients transplanted with leukemia-contaminated grafts, myelomonocytic leukemia WEHI-3B D+ cells were first transduced with a retroviral vector encoding the low-affinity human nerve growth factor receptor (NGFr). Clones with a stable and homogeneous expression of the transgene and with a similar in vitro behavior to the parental cell line were selected for further experiments. The analysis of bone marrow (BM) contaminated with WEHI-3B/NGFr cells revealed a linear correlation (r2 = 0.999) between the actual values of BM contamination and the experimental data determined by flow cytometry. Balb/c mice were myeloablated and transplanted with syngenic BM contaminated with graded numbers of leukemic cells; dose-dependent survival curves were obtained, regardless of whether parental or WEHI-3B/NGFr cells were infused. The leukemia dissemination in recipients transplanted with WEHI-3B/NGFr contaminated grafts was easily determined by means of simple flow cytometry analysis of the NGFr marker. A leukemia dose-dependent increase in the number of PB leukocytes was observed in transplanted recipients at 20 days post-transplantation with no changes in myelomonocytic cells. As deduced from our observations, the transplantation of syngenic BM contaminated with WEHI-3B/NGFr cells constitutes an improved model of autograft-mediated leukemia relapse and a good tool for studies of leukemia cell purging.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gorin NC . Autologous stem cell transplantation in acute myelocytic leukemia Blood 1998 92: 1073–1090
Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H, Rimm AA, Ringdén O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM . Graft-versus-leukemia reactions after bone marrow transplantation Blood 1990 75: 555–562
Brenner MK, Rill DR, Moen RC, Krance RA, Mirro JRJ, Anderson WF, Ihle JN . Gene-marking to trace origin of relapse after autologous bone-marrow transplantation Lancet 1993 341: 85–86
Gamba-Vitalo C, Carman MD, Sartorelli AC . Development of neomycin-resistant WEHI-3B D+ murine cells as an in vivo model of acute nonlymphocytic leukemia Exp Hematol 1989 17: 130–137
Smith C, Muench MO, Knizewski M, Gilboa E, Moore MAS . Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in vivo model of acute non-lymphocytic leukemia Leukemia 1993 7: 310–317
Hendrikx PJ, Martens ACM, Schultz FW, Visser JWM, Hagenbeek A . Monitoring of leukemia growth in a rat model using a highly sensitive assay for the detection of LacZ marked leukemic cells Leukemia 1995 9: 1954–1960
Yang Y, Martens ACM, de Groot CJ, Hendrikx PJ, Valerio DW, van Bekkum DW, Hagenbeek A . Retrovirus-mediated transfer and expression of marker genes in the BN rat acute myelocytic leukemia model for the study of minimal residual disease (MRD) Leukemia 1993 7: 131–139
Mavilio F, Ferrari G, Rossini S, Nobili N, Bonini C, Casorati G, Traversari C, Bordignon C . Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer Blood 1994 83: 1988–1997
Fehse B, Li Z, Schade UM, Uhde A, Zander AR . Impact of a new generation of gene transfer marker on gene therapy Gene Therapy 1998 5: 429–430
Machl AW, Planitzer SA, Kubbies M . I-NGFR receptor is a new flow cytometric tool for rapid cell cycle-correlated gene therapy complementation studies in viable cells Cytometry 1997 29: 371–374
Phillip K, Gentry T, McCowage G, Gilboa E, Smith C . Cell-surface markers for assessing gene transfer into human hematopoietic cells Nature Med 1996 2: 1154–1156
Warner NL, Moore MAS, Metcalf D . A transplantable myelomonocytic leukemia in BALB/c mice: cytology, karyotype, and muramidase content J Natl Cancer Inst 1969 43: 963–982
Muench M, Guy Z, Moore M . Ex vivo differentiation therapy as a method of leukemic cell purging in murine bone marrow expansion cultures Cancer Res 1992 52: 6576–6582
Fuji S, Hamada H, Fujimoto K, Shimomura T, Kawakita M . Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice bearing syngeneic tumors Blood 1999 93: 4328–4335
Nakazaki Y, Tani K, Lin Z, Sumimoto H, Hibino H, Tanabe T, Wu M, Izawa K, Hase H, Takahashi S, Tojo A, Azuma M, Hamada H, Mori S, Asano S . Vaccine effect of granulocyte–macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity Gene Therapy 1998 5: 1355–1362
Cheng L, Du C, Lavau C, Chen S, Tong J, Chen BP, Scollay R, Hawley RG, Hill B . Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and theirlympho-myeloid progeny Blood 1998 92: 83–92
Varas F, Bernad A, Bueren JA . Granulocyte colony-stimulating factor mobilizes into peripheral blood the complete clonal repertoire of hematopoietic precursors residing in the bone marrow of mice Blood 1996 88: 2495–2501
Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rosini S, Mavilio F, Traversari C, Bordignon C . HSV-TK Gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 1997 276: 1719–1724
Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A . Simplified mammalian DNA isolation procedure Nucleic Acids Res 1991 19: 4293
Maniatis T, Fritsch EF, Sambrook J (eds) . Molecular Cloning: a Laboratory Manual Cold Spring Harbor Laboratory: New York 1982
Bernad A, Varas F, Gallego JM, Almendral JM, Bueren JA . Ex vivo expansion and selection of retrovirally transduced bone marrow: and efficient methodology for gene-transfer to murine lympho-haemopoietic stem cells Br J Haematol 1994 87: 6–17
Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF . Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML Blood 1994 83: 3068–3076
Robinet E, Certoux JM, Ferrand C, Maples P, Hardwick A, Cahn JY, Reynolds CW, Jacob W, Herve P, Tiberghien P . A closed culture system for the ex vivo transduction and expansion of human T lymphocytes J Hematother 1998 7: 205–215
Ymer S, Tucker WQ, Sanderson CJ, Hapel AJ, Campbell HD, Young IG . Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene Nature 1985 317: 255–258
Güenechea G . Radioprotección conferida por polisacáridos iónicos en ratón. Relación con su capacidad para estimular el sistema hematopoyético. PhD Thesis, Universidad Complutense deMadrid, 1995
Fung M, Szeto Y, Leung K, Wong-Leung Y, Mak N . Effects of biochain A on the growth and differentiation of myeloid leukemia WEHI-3B (JCS) cells Life Sci 1997 61: 105–115
Acknowledgements
We are grateful to Drs M Grez and H Knoess for providing the packaging cell line producing the LNSN vector. We would like to thank Drs M Ramírez and ML Lamana for discussions and careful reading of the manuscript, and finally S García and ME López for excellent technical collaboration and I Ormán and J Martínez for expert assistance with the flow cytometry and animal studies, respectively. This work was supported by grants of Comisión Interministerial de Ciencia y Tecnología (CICYT, grant SAF 98-0008-C04-01) and Consejería de Educación y Cultura de la Comunidad de Madrid (grant 8.6/19/97). JG-C is a recipient of a fellowship from the CICYT (Plan de formación de personal investigador).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
García-Castro, J., Segovia, J. & Bueren, J. Transplantation of syngenic bone marrow contaminated with NGFr-marked WEHI-3B cells: an improved model of leukemia relapse in mice. Leukemia 14, 457–465 (2000). https://doi.org/10.1038/sj.leu.2401697
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401697
Keywords
This article is cited by
-
Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy
Bone Marrow Transplantation (2006)
-
Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model
Gene Therapy (2003)
-
The enhanced green fluorescent protein as a marker for human tumor cells labelled by retroviral transduction
Chinese Journal of Cancer Research (2002)
-
Leukaemogenic potency of WEHI-3B cells grown in vitro or in leukaemic mice
Bone Marrow Transplantation (2001)